Commonwealth Equity Services, LLC Clearside Biomedical, Inc. Transaction History
Commonwealth Equity Services, LLC
- $70.7 Billion
- Q1 2025
A detailed history of Commonwealth Equity Services, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 22,500 shares of CLSD stock, worth $17,775. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,500
Previous 10,000
125.0%
Holding current value
$17,775
Previous $10,000
110.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLSD
# of Institutions
50Shares Held
11MCall Options Held
5.9KPut Options Held
86.6K-
Vanguard Group Inc Valley Forge, PA2.81MShares$2.22 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$1.74 Million3.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$1.19 Million0.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$630,5280.0% of portfolio
-
Geode Capital Management, LLC Boston, MA792KShares$625,8750.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $47.6M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...